Brief: Talis Biomedical On Aug 12 Filed A Request With U.S. FDA To Revoke Emergency Use Authorization For Talis One Covid-19 Test System
15/08/2022 11:09
Aug 15 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS BIOMEDICAL - ON AUG 12 FILED A REQUEST WITH U.S. FDA
TO
REVOKE EMERGENCY USE AUTHORIZATION FOR TALIS ONE COVID-19 TEST
SYSTEM
* TALIS BIOMEDICAL - FILED REQUEST AFTER NOTIFYING FDA THAT
CO NO
LONGER PLANNED TO PURSUE COMMERCIALIZATION OF TALIS ONE COVID-19
TEST SYSTEM IN U.S.
Source text for Eikon: [ID: https://bit.ly/3JShtGl]
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash